Testing the Addition of Ivonescimab Combined With Standard Chemotherapy Compared to the Usual Chemotherapy and Immunotherapy Treatment for Patients With Advanced Biliary Tract Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Ivonescimab
Related studies linked through entity extraction aliases.
A Phase II Study of Ivonescimab Combined With Intraperitoneal Paclitaxel in Patients With High-Grade Metastatic Appendiceal Adenocarcinoma (AA)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Neoadjuvant Angiogenesis-Targeting Bispecific Chemoimmunotherapy for TNBC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
STOMP OUT: A Phase 2 Study To Evaluate The Effects Of Ivonescimab In Patients With Unresectable/Metastatic Adrenocortical Carcinoma (ACC) Or Unresectable Pheochromocytoma/Paraganglioma (PPGL)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Pilot Study of Ivonescimab in Advanced/Metastatic Cutaneous Angiosarcoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Trastuzumab Rezetecan(SHR-A1811) Combined With Ivonescimab (AK112) in Locally Advanced or Metastatic Non-small Cell Lung Cancer Harboring HER2 Gene Abnormalities
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 in Combination With Ivonescimab in Sq-NSCLC Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Ivonescimab in People With Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Ivonescimab in People With Leiomyosarcoma
- Status
- RECRUITING
- Phase
- PHASE2
Phase II Neoadjuvant Study of Garsorasib Followed by Ivonescimab Plus Chemotherapy in Resectable Stage IIA-IIIB KRAS G12C-Mutant NSCLC (GIVEN Study)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
ctDNA-guided Treatment Decision-making
- Status
- RECRUITING
- Phase
- PHASE2
Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2